Background: Currently, lung transplantation (LTX) is considered to be a curative treatment option in patients with end-stage lung disease. Although pulmonary hypertension (PH), confirmed by cardiac catheterization, is a prognostic factor in patients undergoing LTX, the prognostic value of PH in Asian lung transplant recipients remains uncertain. In this study, we aimed to determine whether PH before LTX may serve as a prognostic factor for survival in Asian patients. Of the 50 patients, 17 (34.0%) died within a year after LTX. The 1-year survival rate among patients with mPAP ≥25 mmHg (58.8%) was lower than the survival rate among patients with mPAP <25 mmHg (87.5%).
Introduction
Management approaches for various intractable lung diseases have been transformed with the advancement of lung transplantation (LTX), which is one of the treatment options utilized at the endpoint of several lung diseases. Transplantation of other solid organs has produced better results and undergone greater improvement than LTX; thus, the outcomes of LTX remain among the worst overall for organ transplantation (1, 2) . However, the frequency and success rate of LTX have improved in recent years, with the increased success attributable to advances in post-LTX immunosuppression treatment (2, 3) ; nevertheless, progress in LTX outcomes remains a challenging area of medicine. The survival rate associated with LTX has been increasing, such that the majority of deaths after LTX occur within the first year (4) . Therefore, the identification of prognostic factors of 1-year mortality in lung transplant recipients might facilitate improvement of long term clinical outcomes after LTX.
There is a growing body of evidence that pulmonary hypertension (PH) associated with lung disease is a predictor of disease severity and mortality in patients awaiting LTX (5) (6) (7) . Patients with PH suffer hypoxia, hypercapnia and respiratory acidosis, as a result of increased peripheral vascular resistance and right heart failure (8, 9) ; these conditions can eventually lead to death. Previous studies have reported that PH, when confirmed by cardiac catheterization, is an independent predictive factor for survival after LTX (7, (10) (11) (12) (13) . In addition, several studies have also analyzed post-LTX prognosis via echocardiography (14) (15) (16) . However, almost all studies were exclusively designed for idiopathic pulmonary fibrosis (IPF) or other individual lung diseases. Moreover, there is a lack of consensus regarding predictive factors between IPF patients and patients who have other lung pathologies (17) .
Despite the increasing popularity of LTX, there continue to be limited reports on the prognostic value of PH in lung transplant recipients. In addition, because of the small number of recipients of LTX in Asia, there are no reports in an Asian population regarding the clinical significance of PH in post-LTX survival. To determine the impact of PH on post-LTX survival, this study analyzed the characteristics and prognoses of lung transplant recipients with or without preoperative PH via echocardiography and right heart catheterization (RHC) in a Korean population.
Methods

Study design and population
We reviewed the medical records of 83 patients who underwent single or double LTX between January 2010 and July 2014 at Severance Hospital, Yonsei University, Republic of Korea. We excluded patients who did not undergo preoperative echocardiography or cardiac catheterization within 1 year prior to LTX, as well as those who missed follow-up echocardiography within 3 months after LTX. Thus, of the 83 patients whose records were initially reviewed, 50 were included in the study. From the database, we extracted all variables related to patient demographic characteristics and pre-and postoperative outcomes, in order to evaluate the relationship between PH and 1-year survival after LTX. Patient survival status was determined on the basis of hospital records. Donor data were collected from the Korean Network of Organ Sharing (KONOS) database. Additional variables included demographic characteristics, ischemic time, and donorrecipient size mismatch. All donated lungs from declared brain-dead patients were preserved in low-potassium dextran solution (Perfadex; Duraent Biologicals, Hyderabad, India). We divided the study subjects into two groups, according to their PH status.
RHC and echocardiography
RHC was performed at rest using a Swan-Ganz catheter. PH was defined as an increase in resting mean pulmonary arterial pressure (mPAP) of ≥25 mmHg, as assessed by RHC, using European Society of Cardiology and European Respiratory Society guidelines (18) . Other echocardiographic variables were collected, such as ejection fraction (EF); right arterial pressure (RAP); regional wall motion abnormality (RWMA); ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E'), i.e., E/E'; and RV systolic pressure (RVSP). The characteristics of echocardiography were compared with RHC data, and correlation analysis was performed to investigate correlations with PH.
Statistical analysis
All data were analyzed using SPSS version 23 Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated. In all statistical analyses, a two-tailed P value of <0.05 was considered to be statistically significant.
Ethical approval
The study protocol was approved by the institutional review board of Severance Hospital (approval No. 2013-0522-019). In addition, this study was conducted in compliance with the principles set in the 2000 Declaration of Helsinki, as well as the 2008 Declaration of Istanbul. Comparison of baseline characteristics revealed that there were significant differences between the two groups regarding most hemodynamic variables, suggesting that hemodynamic variables may act as a prognostic factor; however, the only significant prognostic factors in both univariate analysis and multivariate analysis were mPAP and RAP.
Results
Baseline characteristics of lung transplant recipients
Clinical predictors of 1-year survival after LTX
Of the 50 patients in the study, 17 (34.0%) died within 1 year after LTX. The 1-year survival rate of lung transplant recipients was higher in the PH group; the survival rates of patients with and without PH were 58.8% and 87.0%, respectively (log-rank test, P=0.030; Figure 1 ). Table 2 presents the results of univariate analysis of predictive values for 1-year survival after LTX. Old age, male sex, higher BMI, RAP, and mPAP were identified as independent prognostic factors.
The results of multivariate Cox proportional hazards analysis of age, sex, BMI, underlying disease (IPF vs. non-IPF), and mPAP-all of which were identified as significant prognostic factors in univariate analysis-revealed an HR of 4.832 (95% CI, 1.080-21.608; P=0.039) for survival in patients with mPAP ≥25 mmHg. These results strongly suggest that preoperative PH significantly affects the chances of 1-year survival ( Table 3) . Table 4 presents the comparison of postoperative complications, occurring within 3 months of LTX, in lung transplant recipients. Complications such as sepsis, acute kidney injury, acute rejection, postoperative bleeding, and grade 3 primary graft dysfunction were more frequent in the PH group than in the non-PH group. The proportion of complications was higher in the PH group than in the non-PH group. 
Postoperative complications among lung transplant recipients
Discussion
This study investigated the association between 1-year mortality and preoperative PH among patients who underwent LTX, revealing higher rates of 1-year mortality and postoperative complications among patients with preoperative PH, relative to patients without preoperative PH. Thus, the presence of preoperative PH was associated with an increased risk of postoperative complications and mortality. The presence of PH is a significant prognostic factor in patients with end-stage lung diseases. Among patients with COPD, up to 90% of those with stage IV disease (according to the Global Initiative for Chronic Obstructive Lung Disease guidelines) demonstrate mPAP of >20 mmHg (8) . In addition, the prevalence of PH among patients with IPF ranges from 31.6% to 84% (10, 13, 19) . Similarly, in various lung diseases, most patients develop PH with disease progression (17) . It is interesting to note that, among lung transplant recipients in the present study, preoperative PH was associated with poor Figure 1 Kaplan-Meier survival curve for 1-year mortality after lung transplantation, according to pulmonary hypertension status.
PAP, pulmonary arterial pressure. prognosis for 1-year survival post-LTX. Several studies and guidelines have defined PH as mPAP ≥25 mmHg in patients with or without underlying diseases; in addition, RHC has been utilized as the "gold standard" for PH diagnosis (9, 17, 20) . In the past, chest X-ray imaging and echocardiography were used to determine the presence and severity of PH (17) . However, given its relatively high accuracy in the evaluation of PH status among lung transplant recipients, RHC is increasingly used in preand postoperative evaluation of PH. Although RHC is the most accurate method to diagnose PH, it is an invasive procedure. Therefore, echocardiography is preferred as the initial screening modality for diagnosis of PH. A few studies have used echocardiography to investigate mortality among lung transplant recipients with poor RV function (15, 16, 21) .
However, this diagnostic technology requires estimates of tricuspid regurgitation jet velocity and is associated with underestimation of pressures in patients with high PAP, as well as overestimation of PAP in patients without significant elevation (22, 23) . In the present study, the presence of PH was found in 68% of patients by RHC, whereas it was found in 77% of patients by use of echocardiography [defined as a pulmonary artery systolic pressure (PASP) of >35 mmHg]. Unfortunately, there was no correlation between echocardiography and survival (HR 1.005; 95% CI, 0.984-1.027; P=0.615). There was a positive correlation was observed between PASP estimated by echocardiography and measured by RHC (r=0.584, P<0.001). Although there is a good correlation in baseline PASP between echocardiography and RHC, echocardiographic PH measurements alone are not sufficient to monitor changes in PASP or progression of PH, as described in previous studies (24) . Although it may serve as a good screening tool, echocardiographic PH measurement alone is not sufficient to predict mortality or postoperative outcome. Further large prospective cohort studies are required regarding the diagnosis of PH by echocardiography.
In contrast to the present findings, Whitson et al. reported a lack of strong evidence for a relationship between preoperative PH and postoperative mortality (17) . Furthermore, several studies have been unable to identify a statistically significant difference in survival between patients with PH and patients without PH (25, 26) . Because of these inconsistent results, the impact of preoperative PH on postoperative mortality is still controversial. However, most previous studies, including a large prospective cohort study, have reported high mortality or poor outcomes among lung transplant recipients with PH-associated lung disease (7, (10) (11) (12) (13) 17, 19, (27) (28) (29) (30) . In addition, the variation in the impact of PH on post-transplantation mortality might be attributable to the heterogeneity of end-stage lung diseases among the present study population. In a recent publication, Gries et al. also reported differences in patient survival related to the underlying lung disease (30) .
A growing body of evidence suggests that age at operation, sex, BMI, preoperative albumin level, kidney function, ischemic time, and size mismatch are significant prognostic factors for survival after LTX (7, 21, (30) (31) (32) . The present findings differ from those of some previous reports regarding survival after LTX. In this study, significant prognostic factors for post-LTX survival were limited to age, sex, BMI, and PH (mPAP ≥25 mmHg). Upon multivariate analysis-performed to exclude the effect of non-PH factors, including underlying disease (IPF or non-IPF), on survival-we found that the severity of PH, as defined by mPAP, was a prognostic factor for 1-year survival in lung transplant recipients. Unfortunately, most studies that have evaluated the risk factors of post-LTX mortality were performed in North America and Europe. As the medical environment and causes of LTX in Korea are very different relative to the previous studies, these differences may also affect the prognoses of patients undergoing LTX. Furthermore, the mortality rate in patients awaiting LTX in Korea was higher than in other countries (33) (34) (35) . This may be attributable to the lack of donated lungs and the low utilization rate of donated lungs from brain-dead patients, which are the major obstacles to LTX in Korea, relative to other countries (36) .
To our knowledge, this was the first study to evaluate the clinical significance of post-LTX PH in Asian patients. Our results clearly demonstrated a significant correlation between mPAP and 1-year survival after LTX. In addition, the rate and severity of postoperative complications, such as sepsis, multi-organ dysfunction, postoperative bleeding, postoperative gastrointestinal bleeding, and grade 3 primary graft dysfunction, were higher among patients with PH than among patients without PH. For these reasons, we believe that PH is a significant prognostic factor for post-LTX survival.
In chronic lung diseases associated with PH, RV function is strongly influenced by the afterload (i.e., the underlying lung disease status) (17) . Additionally, PH also causes distortion of cardiac geometry; however, post-LTX echocardiographic findings have demonstrated reverse remodeling of the distorted cardiac geometry (37). Thus, for a variety of reasons, severe pulmonary disease affects both the right and left ventricles and leads to PH (38) , which is considered to be associated with increased mortality. There is an increasing effort to produce evidence supporting this claim in specific lung diseases, such as cystic fibrosis (26, 39, 40) . Collectively, these findings suggest that the presence of PH before LTX might affect the prognosis in lung transplant recipients. Therefore, further studies, involving a large number of patients with various endstage lung diseases, are required to evaluate the prognostic implication of preoperative PH in the clinical outcome of LTX.
Limitations of the present study include its relatively small sample size and retrospective study design solely involving medical record review. In addition, there is no apparent difference in the prognosis between severe PH and mild to moderate PH; this requires additional investigation. Despite these limitations, the strength of this study is that this was the first study to evaluate the prognostic significance of preoperative PH in Asian patients; moreover, the data were derived from a single center cohort. Considering that differences in ethnicity influence the outcome in patients with end-stage lung disease, data from our study could provide useful information regarding the prognosis of Asian patients undergoing LTX.
In conclusion, patients with PH exhibited higher 1-year mortality after LTX, relative to patients without PH. PH associated with lung disease has been shown to be a predictor of the severity of disease and mortality in patients awaiting LTX. Thus, the evaluation of PH by preoperative RHC might be essential in patients who are awaiting LTX. Larger prospective studies are required to verify the benefit of early transplantation in patients with PH, following evaluation by echocardiography and RHC. Furthermore, earlier transplantation should be considered before the occurrence of end-stage lung disease in patients with PH.
